Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 76 Schemes (51.97%)
Foreign Institutions
Held by 98 Foreign Institutions (7.6%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
570 Million
(Quarterly Results - Mar 2026)
Net Profit:
51 Million
Pharmaceuticals & Biotechnology
USD 2,910 Million (Small Cap)
16.00
NA
0.00%
-79.90
-999,999.00%
0.00






